13.01
price down icon2.25%   -0.30
after-market Dopo l'orario di chiusura: 13.07 0.06 +0.46%
loading

Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
12.18%
66.77
59.52 51.44 49.25 45.85
Operating Income/Loss
12.18%
-66.77
-59.52 -51.44 -49.25 -45.85
Income/Loss From Continuing Operations Before Tax
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Income/Loss From Continuing Operations After Tax
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Net Income/Loss
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,046%
86.68
2.0908 85.95 74.96 71.97
Diluted Average Shares
4,046%
86.68
2.0908 85.95 74.96 71.97
Basic Earnings Per Share
12.50%
-0.72
-0.64 -0.54 -0.61 -0.59
Diluted Earnings Per Share
12.50%
-0.72
-0.64 -0.54 -0.61 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):